Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione (Q68748405)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2322991 AND SRC:MED&resulttype=core&format=json

27 September 2019

title

Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2322991 AND SRC:MED&resulttype=core&format=json

27 September 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2322991 AND SRC:MED&resulttype=core&format=json

27 September 2019

author name string

M Dowsett

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2322991 AND SRC:MED&resulttype=core&format=json

27 September 2019

A Hedley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2322991 AND SRC:MED&resulttype=core&format=json

27 September 2019

J Davenport

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2322991 AND SRC:MED&resulttype=core&format=json

27 September 2019

J C Gazet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2322991 AND SRC:MED&resulttype=core&format=json

27 September 2019

H T Ford

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2322991 AND SRC:MED&resulttype=core&format=json

27 September 2019

R C Coombes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2322991 AND SRC:MED&resulttype=core&format=json

27 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2322991 AND SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

27 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2322991 AND SRC:MED&resulttype=core&format=json

27 September 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2322991 AND SRC:MED&resulttype=core&format=json

27 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2322991 AND SRC:MED&resulttype=core&format=json

27 September 2019

page(s)

75-78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2322991 AND SRC:MED&resulttype=core&format=json

Aminoglutethimide in treatment of metastatic breast carcinoma

27 September 2019

cites work

1 reference

12 December 2020

Stereoselective Inhibition of Aromatase by Enantiomers of Aminoglutethimide*

1 reference

12 December 2020

4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer

1 reference

12 December 2020

Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Identification of the glucuronide as a major urinary metabolite in patients and biliary metabolite in the rat.

1 reference

12 December 2020

Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial

1 reference

12 December 2020

Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report

1 reference

12 December 2020

Oral 4-hydroxyandrostenedione, a new endocrine treatment for disseminated breast cancer

1 reference

12 December 2020

Steroid receptors in human breast cancer

1 reference

12 December 2020

Improved sensitivity in the measurement of estrogen receptor in human breast cancer.

1 reference

12 December 2020

The Effect of an Aromatase Inhibitor, 4-Hydroxy-4-Androstene- 3,17-Dione, On Estrogen-Dependent Processes in Reproduction and Breast Cancer11

1 reference

12 December 2020

Proceedings: Medical adrenalectomy using aminoglutethimide and dexamethasone in advanced breast cancer

1 reference

12 December 2020

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

12 December 2020

Treatment of disseminated breast cancer with tamoxifen, aminoglutethimide, hydrocortisone, and danazol, used in combination or sequentially

1 reference

12 December 2020

Tamoxifen in advanced breast cancer

1 reference

12 December 2020

Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02940300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2322991 AND SRC:MED&resulttype=core&format=json

27 September 2019

1 reference